Mn Services Vermogensbeheer B.V. Edwards Lifesciences Corp Transaction History

Mn Services Vermogensbeheer B.V.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$102.91 - $122.75 $47.1 Million - $56.2 Million	-457,990 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$83.84 - $104.76 $8 Million - $9.99 Million	-95,400 Reduced 17.24%	457,990 $40 Million
Q4 2020 Feb 09, 2021	BUY	$71.69 - $91.23 $695,393 - $884,931	9,700 Added 1.78%	553,390 $50.5 Million
Q3 2020 Nov 04, 2020	BUY	$67.19 - $87.44 $604,710 - $786,960	9,000 Added 1.68%	543,690 $43.4 Million
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $20.6 Million - $27.6 Million	358,160 Added 202.89%	534,690 $37 Million
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $644,643 - $996,300	-12,300 Reduced 6.51%	176,530 $33.3 Million
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $336,990 - $385,823	4,700 Added 2.55%	188,830 $44.1 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $4.77 Million - $5.85 Million	77,498 Added 72.68%	184,130 $40.5 Million
Q2 2019 Jul 25, 2019	SELL	$55.74 - $64.41 $512,808 - $592,572	-9,200 Reduced 7.94%	106,632 $19.7 Million
Q1 2019 May 06, 2019	BUY	$47.89 - $64.05 $52,679 - $70,455	1,100 Added 0.96%	115,832 $22.2 Million
Q4 2018 Feb 12, 2019	BUY	$46.41 - $56.94 $3.78 Million - $4.64 Million	81,430 Added 244.52%	114,732 $15.4 Million
Q1 2018 May 11, 2018	BUY	$37.19 - $47.45 $26,033 - $33,215	700 Added 2.15%	33,302 $4.65 Million
Q4 2017 Feb 02, 2018	SELL	$33.79 - $39.39 $67,580 - $78,780	-2,000 Reduced 5.78%	32,602 $3.06 Million
Q3 2017 Nov 01, 2017	BUY	$36.29 - $38.83 $1.26 Million - $1.34 Million	34,602	34,602 $3.78 Million

1,364

470M

9.76M

3.89M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.